• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国重庆接受治疗的中老年HIV感染者中动脉粥样硬化性心血管疾病的发病率及危险因素

Incidence and risk factors regarding atherosclerotic cardiovascular disease in middle-aged and elderly people with HIV treated in Chongqing, China.

作者信息

Liu Min, Li Mei, Liu Qian, Fu Yongjia, Wu Yushan, Huang Rui, Cao Qi, Yang Honghong

机构信息

Division of Infectious Diseases, Chongqing Public Health Medical Center, 109 Baoyu Road, Shapingba District, Chongqing, 400036, China.

出版信息

AIDS Res Ther. 2024 Dec 19;21(1):92. doi: 10.1186/s12981-024-00684-7.

DOI:10.1186/s12981-024-00684-7
PMID:39702183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11660838/
Abstract

BACKGROUND

Atherosclerotic cardiovascular disease (ASCVD) has become an increasingly common cause of death among people living with HIV (PLHIV) receiving successful antiretroviral therapy (ART). In Chongqing, approximately half of the PLHIV were middle-aged or elderly, and their diets were mainly high in salt, spices and oil; however, there is still a lack of relevant research on the risk factors and whether the disease burden of ASCVD is greater in these areas. This study was to investigate the risk of ASCVD in middle-aged and elderly PLHIV receiving ART and analyze the factors influencing high risk.

METHODS

A cross-sectional study was conducted at Chongqing Public Health Medical Center. Questionnaire surveys, physical examinations and laboratory examinations were used to collect information from PLHIV aged ≥ 45 years. Pooled cohort equations (PCEs) were used to calculate the 10-year ASCVD risk and analyze the influencing factors. The 10-year ASCVD risk score was used to define patients in the low-risk subgroup (< 7.5%) and high-risk subgroup (≥ 7.5%), and the risk factors were compared between the two groups.

RESULTS

In total, 463 PLHIV (median age 55.0 years, male 68.5%) were included, and the median duration of ART was 45.0 (15.0, 70.3) months. Of the 463 PLHIV, 13 (2.8%) had a known history of ASCVD. In the present study, 153 PLHIV (33.0%) were classified into the high-risk group, and 310 PLHIV (67.0%) were classified into the low-risk group. Compared with the low-risk group, the high-risk group was more likely to be female, older age, live in urban areas, be unemployed, have poor sleep quality, have higher low-density lipoprotein cholesterol (LDL-c), have higher total cholesterol (TC), and have diabetes and hypertension; however, coffee consumption was associated with a low risk of ASCVD. In addition, there were no differences in HIV viral load, CD4 + T-cell count, or duration on ART, or ART regimes between the two groups. According to multiple logistic regression, older age [odds ratio (OR) = 62.469, 95% CI 27.456, 142.134], female sex [OR = 9.635, 95% CI 4.384, 21.179], higher LDL-c levels [OR = 1.018, 95% CI 1.000, 1.036], accompanied hypertension [OR = 8.642, 95% CI 3.373, 22.143] and diabetes [OR = 10.806, 95% CI 3.787, 30.834] were found to be independent risk factors for the 10-year risk of ASCVD.

CONCLUSIONS

The overall 10-year ASCVD risk is great for middle-aged and elderly PLHIV in Chongqing, China. The risk factors for the 10-year risk of ASCVD were older age, female sex, elevated LDL-c level, and coexisting hypertension and diabetes.

摘要

背景

在接受成功抗逆转录病毒治疗(ART)的人类免疫缺陷病毒感染者(PLHIV)中,动脉粥样硬化性心血管疾病(ASCVD)已成为日益常见的死亡原因。在重庆,约一半的PLHIV为中年或老年人,他们的饮食主要高盐、多香料和多油;然而,在这些地区,关于ASCVD的危险因素以及疾病负担是否更大仍缺乏相关研究。本研究旨在调查接受ART的中年和老年PLHIV发生ASCVD的风险,并分析影响高危的因素。

方法

在重庆公共卫生医疗中心进行一项横断面研究。采用问卷调查、体格检查和实验室检查收集年龄≥45岁的PLHIV的信息。使用合并队列方程(PCEs)计算10年ASCVD风险并分析影响因素。使用10年ASCVD风险评分定义低风险亚组(<7.5%)和高风险亚组(≥7.5%)的患者,并比较两组之间的危险因素。

结果

共纳入463例PLHIV(中位年龄55.0岁,男性占68.5%),ART的中位疗程为45.0(15.0,70.3)个月。在这463例PLHIV中,13例(2.8%)有ASCVD病史。在本研究中,153例PLHIV(33.0%)被分类为高风险组,310例PLHIV(67.0%)被分类为低风险组。与低风险组相比,高风险组更可能为女性、年龄较大、居住在城市地区、失业、睡眠质量差、低密度脂蛋白胆固醇(LDL-c)较高、总胆固醇(TC)较高,且患有糖尿病和高血压;然而,喝咖啡与ASCVD低风险相关。此外,两组之间的HIV病毒载量、CD4+T细胞计数、ART疗程或ART方案无差异。根据多因素logistic回归分析,年龄较大[比值比(OR)=62.469,95%置信区间(CI)27.456,142.134]、女性[OR=9.635,95%CI 4.384,21.179]、较高的LDL-c水平[OR=1.018,95%CI 1.000,1.036]、伴有高血压[OR=8.642,95%CI 3.373,22.143]和糖尿病[OR=10.806,95%CI 3.787,30.834]被发现是10年ASCVD风险的独立危险因素。

结论

在中国重庆,中年和老年PLHIV的总体10年ASCVD风险较高。10年ASCVD风险的危险因素为年龄较大、女性、LDL-c水平升高以及并存高血压和糖尿病。

相似文献

1
Incidence and risk factors regarding atherosclerotic cardiovascular disease in middle-aged and elderly people with HIV treated in Chongqing, China.中国重庆接受治疗的中老年HIV感染者中动脉粥样硬化性心血管疾病的发病率及危险因素
AIDS Res Ther. 2024 Dec 19;21(1):92. doi: 10.1186/s12981-024-00684-7.
2
Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross-sectional analysis in Chongqing, China.中国重庆地区抗逆转录病毒治疗人群中代谢综合征的流行情况、危险因素及靶器官损害:一项横断面分析。
HIV Med. 2024 May;25(5):529-539. doi: 10.1111/hiv.13605. Epub 2023 Dec 29.
3
Assessment of atherosclerotic cardiovascular disease risks between people living with HIV receiving first-line and second-line antiretroviral therapy in a resource-limited setting.在资源有限的环境中,评估接受一线和二线抗逆转录病毒疗法的 HIV 感染者的动脉粥样硬化性心血管疾病风险。
Int J STD AIDS. 2021 Apr;32(5):421-426. doi: 10.1177/0956462420972855. Epub 2021 Feb 3.
4
Sex modifies the association between HIV and coronary artery disease among older adults in Uganda.性行为改变了乌干达老年人中 HIV 和冠心病之间的关联。
J Int AIDS Soc. 2022 Jan;25(1):e25868. doi: 10.1002/jia2.25868.
5
Changes in atherosclerotic cardiovascular disease risk over time among people living with HIV.随着时间的推移,艾滋病毒感染者动脉粥样硬化性心血管疾病风险的变化。
J Antimicrob Chemother. 2024 Apr 2;79(4):897-902. doi: 10.1093/jac/dkae049.
6
Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study.依洛尤单抗在血脂异常的 HIV 感染患者中的应用:BEIJERINCK 随机、双盲研究的主要结果。
J Am Coll Cardiol. 2020 May 26;75(20):2570-2584. doi: 10.1016/j.jacc.2020.03.025. Epub 2020 Mar 28.
7
Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis.泰国艾滋病毒感染者他汀类药物起始治疗的动脉粥样硬化性心血管疾病阈值:成本效益分析。
PLoS One. 2021 Sep 9;16(9):e0256926. doi: 10.1371/journal.pone.0256926. eCollection 2021.
8
Impact of Perceived Cardiovascular Risk on Cardiovascular Disease Prevention Behaviors in People With and Without HIV Infection.感知心血管风险对 HIV 感染者和非感染者心血管疾病预防行为的影响。
J Acquir Immune Defic Syndr. 2020 Apr 15;83(5):513-521. doi: 10.1097/QAI.0000000000002290.
9
Advanced HIV disease and associated factors among young people aged 15-24 years at a tertiary hospital in Sierra Leone: a cross-sectional study.塞拉利昂一家三级医院中 15-24 岁年轻人的艾滋病晚期疾病及相关因素:一项横断面研究。
BMC Infect Dis. 2024 Jun 20;24(1):611. doi: 10.1186/s12879-024-09524-5.
10
Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.埃塞俄比亚北谢瓦接受联合抗逆转录病毒治疗的艾滋病毒感染患者血脂异常的患病率。
PLoS One. 2021 Apr 27;16(4):e0250328. doi: 10.1371/journal.pone.0250328. eCollection 2021.

本文引用的文献

1
Changes in Atherosclerotic Cardiovascular Disease Risk Scores in a Predominantly Black Cohort with HIV and Associated Comorbidities: A Preliminary Study.在以黑人为主的感染HIV及相关合并症队列中动脉粥样硬化性心血管疾病风险评分的变化:一项初步研究
Cardiology. 2025;150(2):194-202. doi: 10.1159/000540526. Epub 2024 Aug 6.
2
Prevalence of Clinical Cardiovascular Disease Risk Factors Among HIV Infected Patients on Anti-Retroviral Treatment in a Tertiary Hospital in Ethiopia.埃塞俄比亚一家三级医院接受抗逆转录病毒治疗的艾滋病毒感染患者临床心血管疾病危险因素的患病率
HIV AIDS (Auckl). 2022 Jun 17;14:297-309. doi: 10.2147/HIV.S362459. eCollection 2022.
3
Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China.中国动脉粥样硬化性心血管疾病风险与降脂治疗需求
Front Cardiovasc Med. 2022 Mar 28;9:839571. doi: 10.3389/fcvm.2022.839571. eCollection 2022.
4
Predicting the risk of atherosclerotic cardiovascular disease among adults living with HIV/AIDS in Addis Ababa, Ethiopia: A hospital-based study.预测埃塞俄比亚亚的斯亚贝巴艾滋病病毒/艾滋病患者的动脉粥样硬化性心血管疾病风险:一项基于医院的研究。
PLoS One. 2021 Nov 29;16(11):e0260109. doi: 10.1371/journal.pone.0260109. eCollection 2021.
5
Prediction of future cardiovascular events by Framingham, SCORE and asCVD risk scores is less accurate in HIV-positive individuals from the HIV-HEART Study compared with the general population.与普通人群相比,来自 HIV-HEART 研究的 HIV 阳性个体中,Framingham、SCORE 和 asCVD 风险评分预测未来心血管事件的准确性较低。
HIV Med. 2021 Sep;22(8):732-741. doi: 10.1111/hiv.13124. Epub 2021 May 24.
6
Risks of cardio-vascular diseases among highly active antiretroviral therapy (HAART) treated HIV seropositive volunteers at a treatment centre in Lagos, Nigeria.在尼日利亚拉各斯的一家治疗中心,接受高效抗逆转录病毒疗法 (HAART) 治疗的 HIV 血清阳性志愿者中心血管疾病的风险。
Pan Afr Med J. 2021 Feb 23;38:206. doi: 10.11604/pamj.2021.38.206.26791. eCollection 2021.
7
Independent Risk Factors for Deaths due to AIDS in Chongqing, China: Does Age Matter?中国重庆艾滋病死亡的独立危险因素:年龄有影响吗?
Front Med (Lausanne). 2021 Feb 17;7:586390. doi: 10.3389/fmed.2020.586390. eCollection 2020.
8
Higher Risks of Virologic Failure and All-Cause Deaths Among Older People Living with HIV in Chongqing, China.中国重庆老年HIV感染者病毒学失败和全因死亡风险更高。
AIDS Res Hum Retroviruses. 2019 Nov/Dec;35(11-12):1095-1102. doi: 10.1089/AID.2019.0096. Epub 2019 Oct 29.
9
Estimated risk of cardiovascular disease among the HIV-positive patients aged 40 years or older in Taiwan.在台湾,40 岁或以上的 HIV 阳性患者的心血管疾病预估风险。
J Microbiol Immunol Infect. 2019 Aug;52(4):549-555. doi: 10.1016/j.jmii.2019.03.006. Epub 2019 Apr 11.
10
Lipid Abnormalities in Persons Living With HIV Infection.HIV 感染者的脂类异常。
Can J Cardiol. 2019 Mar;35(3):249-259. doi: 10.1016/j.cjca.2018.11.005. Epub 2018 Nov 15.